Edwards Lifesciences Raises Annual Sales Guidance
29 Julho 2021 - 05:51PM
Dow Jones News
By Maria Armental
Edwards Lifesciences Corp. raised sales projections for the
year, following stronger-than-expected second-quarter results.
The company now expects $5.2 billion to $5.4 billion in sales,
up from its previous view of $4.9 billion to $5.3 billion in sales,
and expects adjusted profit at the high end of the previous range
of $2.07 to $2.27 a share.
This quarter, the medical-device company expects 50 cents to 56
cents a share in adjusted profit and $1.29 billion to $1.37 billion
in sales, compared with analysts' projected 55 cents a share in
profit and $1.3 billion in sales, according to FactSet.
"As patients and clinicians increasingly recognize the
significant benefits of our less-invasive therapies, supported by
the growing body of compelling evidence, we remain optimistic about
the long-term growth opportunity," Chief Executive Michael A.
Mussallem said in a statement.
Write to Maria Armental at maria.armental@wsj.com
(END) Dow Jones Newswires
July 29, 2021 16:39 ET (20:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Edwards Lifesciences (NYSE:EW)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Edwards Lifesciences (NYSE:EW)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024